Login
No login? Register now to unlock hella tokens
No login? Register now to unlock hella tokens
Log In person
Guardant Health Inc logo
Guardant Health Inc GH
summarize 2 total product lines
calendar_month Revenue as of 12/31/2023
Reporting Segmentarrow_drop_up Product Line Amount (USD) Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Precision Oncology
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Diversified Payors
These companies operate Genetic, Genomic, and Sequencing diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. Revenue is ultimately derived from commercial insurance providers, consumers as well as medicare and medicaid.
514.25M 91.19%
Precision Oncology
Contract Clinical Testing Services for Drug Manufacturers
These companies provide contract clinical testing services to pharmaceutical and biotechnology companies. These services can be employed anywhere from early-stage to late-stage drug development. In the process of providing these testing services, the companies gain approval from relevant regulatory agencies.
49.7M 8.81%
keyboard_arrow_right keyboard_arrow_down
Precision Oncology
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Diversified Payors
514.25M 91.19%
keyboard_arrow_right
These companies operate Genetic, Genomic, and Sequencing diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. Revenue is ultimately derived from commercial insurance providers, consumers as well as medicare and medicaid.
keyboard_arrow_right keyboard_arrow_down
Precision Oncology
Contract Clinical Testing Services for Drug Manufacturers
49.7M 8.81%
keyboard_arrow_right
These companies provide contract clinical testing services to pharmaceutical and biotechnology companies. These services can be employed anywhere from early-stage to late-stage drug development. In the process of providing these testing services, the companies gain approval from relevant regulatory agencies.